Holding(s) In Company
Heights Capital Management, Inc., through its subsidiary CVI Investments, Inc., has acquired a significant stake in Faron Pharmaceuticals OY, crossing a notification threshold on April 15, 2026. The entity now holds 10.13% of voting rights attached to shares and 15.44% through financial instruments, resulting in a total holding of 25.58% of the total voting rights, which equates to 51,929,014 voting rights. This represents an increase from their previous notification where they held 8.37% of voting rights and 16.82% through financial instruments, totaling 25.19%.
Select text to share a quote on X · sign in to keep highlights & notes in your FARN notes
| Faron Pharmaceuticals Ltd | Company announcement | April 20, 2026 at 10:15:00 EEST |
FARON PHARMACEUTICALS LTD: HOLDING(S) IN COMPANY
TR-1: Standard form for notification of major holdings
- Please indicate if the issuer is a non-UK issuer (please mark with an “X” if appropriate)
| Non-UK issuer | X |
- Reason for the notification (please mark the appropriate box or boxes with an “X”)
| An acquisition or disposal of voting rights | X |
An acquisition or disposal of financial instruments
An event changing the breakdown of voting rights
Other (please specify) iii :
Details of person subject to the notification obligation iv
| Name | Heights Capital Management, Inc. |
| City and country of registered office (if applicable) | San Francisco, California |
Full name of shareholder(s) (if different from 3.) v
| Name | CVI Investments, Inc. |
| City and country of registered office (if applicable) | Cayman Islands |
| 5. Date on which the threshold was crossed or reached vi : | 15/04/2026 |
| 6. Date on which issuer notified (DD/MM/YYYY): | 15/04/2026 |
- Total positions of person(s) subject to the notification obligation
| Resulting situation on the date on which threshold was crossed or reached | 10.13% | 15.44% | 25.58% | 51,929,014 |
| Position of previous notification (if applicable) | 8.37% | 16.82% | 25.19% | |
| A: Voting rights attached to shares | ||||
| Class/type of shares ISIN code (if possible) | Number of voting rights ix | % of voting rights | ||
| Direct (DTR5.1) | Indirect (DTR5.2.1) | Direct (DTR5.1) | Indirect (DTR5.2.1) | |
| FI4000153309 | 20,569,014 | 31,360,000 | 10.13% | 15.44% |
| SUBTOTAL 8. A | 51,929,014 | 25.58% | ||
| B 1: Financial Instruments according to DTR5.3.1R (1) (a) | ||||
| Convertible Bond | 08/02/2027 | Anytime until maturity | 13,440,000 | 6.62% |
| Convertible Bond | 12/02/2028 | Anytime until maturity | 17,920,000 | 8.83% |
| SUBTOTAL 8. B 1 | 31,360,000 | 15.44% | ||
B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)
SUBTOTAL 8.B.2
| Heights Capital Management, Inc. | 10.13% | 15.44% | 25.58% |
| CVI Investments, Inc. | 10.13% | 15.44% | 25.58% |
In case of proxy voting, please identify:
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
Additional information xvi
None
| Place of completion | London, United Kingdom |
|---|---|
| Date of completion | 15.04.2026 |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.